← Back to Search

Physical Activity (PA) Intervention for Multiple Sclerosis

N/A
Waitlist Available
Led By E. Ann Yeh, MA, MD, FRCPC, Dip ABPN
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up entire study - up to 18 months
Awards & highlights

Study Summary

This trial will study a physical activity intervention for youth with MS.

Eligible Conditions
  • Pediatric Multiple Sclerosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~entire study - up to 18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and entire study - up to 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Physical Activity Level
Secondary outcome measures
Aerobic Capacity
Self-Reported PA Outcomes
Social Cognitive Theory Based Mediators of Physical Activity
Other outcome measures
Measures: Anxiety
Measures: Cognitive Function
Measures: Depression
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Waitlist attention-controlExperimental Treatment1 Intervention
The participant receives the control condition for 6 months following baseline measurements. After 6 months, the baseline measurements are repeated and then the participant receives the intervention.
Group II: InterventionExperimental Treatment1 Intervention
The participant receives the intervention immediately following baseline measurements.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Physical Activity (PA) Intervention
2019
N/A
~30

Find a Location

Who is running the clinical trial?

National Multiple Sclerosis SocietyOTHER
96 Previous Clinical Trials
9,449 Total Patients Enrolled
94 Trials studying Multiple Sclerosis
9,095 Patients Enrolled for Multiple Sclerosis
The Hospital for Sick ChildrenLead Sponsor
692 Previous Clinical Trials
6,946,544 Total Patients Enrolled
5 Trials studying Multiple Sclerosis
185 Patients Enrolled for Multiple Sclerosis
Children's Hospital of PhiladelphiaOTHER
710 Previous Clinical Trials
8,588,852 Total Patients Enrolled
4 Trials studying Multiple Sclerosis
1,473 Patients Enrolled for Multiple Sclerosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there current openings for enrollment in this medical experiment?

"According to the available information on clinicaltrials.gov, this study is actively welcoming participants into its ranks. This research initiative was first posted in December of 2020 and recently updated on March 15th 2022."

Answered by AI

How many participants are allowed to register for this trial?

"This clinical trial necessitates 56 qualified participants, and these volunteers may come from The Hospital for Sick Children in Toronto or the Children's Hospital of Philadelphia. Meeting the specified inclusion criteria is mandatory to partake in this experiment."

Answered by AI

Are younger individuals under 45 eligible to participate in this trial?

"This medical study is only open to people between the ages of 11 and 21. The total number of trials available for patients below 18 amounts to 43, while 391 are designated for those over 65 years old."

Answered by AI

To what extent is eligibility limited for participation in this research?

"The current trial is recruiting 56 youths aged 11-21, who suffer from sclerosis and do not partake in more than 3 hours of structured physical activity per week."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
~13 spots leftby May 2025